Alpa Laboratories Ltd. (ALPA) - Stock Overview & Analysis

Search your stocks

Profile

ALPAAlpa Laboratories Ltd.

₹94.88+0.58%

Market Cap

₹202.09 Cr

Stock P/E

10.27

ROCE

14.31%

ROE

11.71%

Book Value

₹72.20

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Others

Financials

YoY Net Sales

EPS Growth

Operating Margin

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Alpa Laboratories Ltd. shows competitive metrics within the Pharmaceuticals & Drugs sector, particularly with a low PE ratio and solid profitability indicators, suggesting it is an undervalued player. However, it lags in growth compared to top performers in the sector, indicating potential for improvement.

Key Points

• Alpa Laboratories has a low PE ratio of 10.27, indicating undervaluation relative to peers.
• It boasts a reasonable ROE of 11.71%, contributing to its profitability.
• Revenue growth is modest at 3.41% YoY, suggesting less aggressive expansion than competitors.

Top Performers

Dr. Reddy's Laboratories Ltd.

Highest profitability with strong ROE and growth metrics.

Cipla Ltd.

Strong revenue growth and operational efficiency with solid margins.

Mankind Pharma Ltd.

Best revenue growth trajectory and efficiency in returns.